Matthews D, Mosconi M, Andrews R, Rickert K, Tsui WH, Li Yi, Mistur R, de Leon M, and the Alzheimer’s
Disease Neuroimaging Initiative.  Regional Cerebral Glucose Metabolism at Baseline Predicts Symptom
Onset in Normal ADNI Subjects and Correlates to Disease Progression.  Abstract, presented at ADNI
Investigators Meeting April, 2009.

Matthews D, Mosconi M, Andrews R, Brown T, Rickert K, Tsui WH, Li Yi, Mistur R, de Leon M, and the
Alzheimer’s Disease Neuroimaging Initiative. Combining Amyloid Imaging and Measurement of
Regional Cerebral Glucose Metabolism to Evaluate Dementia State and Progression.  Abstract,
presented at Human Amyloid Imaging Meeting, April 2009.

Matthews D, Mosconi M, Andrews R, Rickert K, Tsui WH, Li Yi, de Leon M, and the Alzheimer’s Disease
Neuroimaging Initiative.  Hippocampal Glucose Metabolism Predicts Cognitive Decline and Correlates to
Disease Progression in the ADNI Population.  Abstract, presented at the International Conference on
Alzheimer's Disease (ICAD), July 2009.

Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B,
Wisniewski T, de Leon MJ. FDG-PET changes in brain glucose metabolism from normal cognition to
pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2009 May;36(5):811-22.

Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E,
Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, Kurz A, Minoshima S,
de Leon MJ.  Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's
disease, and other dementias. J Nucl Med. 2008 Mar;49(3):390-8.

Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ.
Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging. 2008 May;
29(5):676-92.

Mosconi L, De Santi S, Brys M, Tsui WH, Pirraglia E, Glodzik-Sobanska L, Rich KE, Switalski R, Mehta
PD, Pratico D, Zinkowski R, Blennow K, de Leon MJ.   Hypometabolism and Altered Cerebrospinal Fluid
Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints.  Biol Psychiatry.
2007 Aug 24; [Epub ahead of print]

Mosconi L, Tsui WH, Pupi A, De Santi S, Drzezga A, Minoshima S, de Leon MJ. (18)F-FDG PET database
of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment
and Alzheimer's disease.  J Nucl Med. 2007 Jul;48(7):1129-34.

Mosconi L, Tsui WH, Rusinek H, De Santi S, Li Y, Wang GJ, Pupi A, Fowler J, de Leon MJ.   Quantitation,
regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease.  
Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1467-79.

Mosconi L et al.  Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image
analysis.  Neurology. 2005, Jun 14:64(11):1860-7.

Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, Convit A, de Leon MJ.  Atrophy rate in medial
temporal lobe during progression of Alzheimer disease.  Neurology. 2004 Dec 28;63(12):2354-9.

Rusinek H, De Santi S, Frid D, Tsui WH, Tarshish CY, Convit A, de Leon MJ.  Regional brain atrophy rate
predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology. 2003
Dec;229(3):691-6.

Strother SC, Anderson J, Hansen LK, Kjems U, Kustra R, Sidtis J, Frutiger S, Muley S, LaConte S,
Rottenberg D.  The quantitative evaluation of functional neuroimaging experiments: the NPAIRS data
analysis framework.  Neuroimage.  2002 Apr;15(4):747-71.
Copyright 2006-2010 Abiant, Inc.
References
Abiant, Inc.  420 Lake Cook Road, Suite 111, Deerfield, Illinois  60015   
Diagnosis...